Stepwise approach to myopathy in systemic disease

Frontiers in Neurology

Volumn AUG, Issue , 2011, Pages

  Chawla, Jasvinder ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

CIM; CK; EMG; HIV; HMG CoA; HyperCKemia; IVIgG

Indexed keywords

EID: 84865737325     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2011.00049     Document Type: Article

References (72)

1. Abd, T. T., and Jacobson, T. A. (2011). Statin-induced myopathy: a review and update. Expert Opin. Drug Saf. 10, 373-387.
2. Abdel-Hamid, H., Oddis, C. V., and Lacomis, D. (2008). Severe hydrox-ychloroquine myopathy. Muscle Nerve 38, 1206-1210.
3. Adeniyi, O., Agaba, E. I., King, M., Servilla, K. S., Massie, L., and Tza-maloukas, A. H. (2004). Severe prox-imal myopathy in advanced renal failure. Diagnosis and management. Afr. J. Med. Med. Sci. 3, 385-388.
4. Al-Najar, M., Obeidat, F., Ajlouni, J., Mithqal, A., and Hadidy, A. (2010). Primary extensive pyomyositis in an immunocompetent patient: case report and literature review. Clin. Rheumatol. 29, 1469-1472.
5. Al-Said, Y. A., Al-Rached, H. S., Al-Qahtani, H. A., and Jan, M. M. (2009). Severe proximal myopathy with remarkable recovery after vita-min D treatment. Can. J. Neurol. Sci. 36, 336-339.
6. Amanzadeh, J., and Reilly, R. F. Jr. (2006). Hypophosphatemia: an evidence-based approach to its clin-ical consequences and management. Nat. Clin. Pract. Nephrol. 2, 136-148.
7. Antoine, J. C., and Camdessanché, J. P. (2007). Peripheral nervous system involvement in patients with cancer. Lancet Neurol., 6, 75-86.
8. Apostolidis, L., Kahlert, C., Siegmund, A., Thom, R., Horstmann, S., Jäger, D., and Lordick, F. (2009). Remis-sion of paraneoplastic dermato-myositis associated with hepatocel-lular carcinoma under prednisolone and azathiopin, and concommittant sorafenib. Onkologie 32, 50-53.
9. Assadi, F. (2010). Hypophosphatemia: an evidence-based problem-solving approach to clinical cases. Iran. J. Kidney Dis. 4, 195-201.
10. Baker, S. K., Vladutiu, G. D., Peltier, W. L., Isackson, P. J., and Tarnopolsky, M. A. (2008). Metabolic myopathies discovered during investigations of statin myopathy. Can. J. Neurol. Sci. 35, 94-97.
11. Brancaccio, P., Lippi, G., and Maffulli, N. (2010). Biochemical markers of muscular damage. Clin. Chem. Lab. Med. 48, 757-767.
12. Cantarini, L., Volpi, N., Galeazzi, M., Giani, T., Fanti, F., Lucherini, O. M., Aglianò, M., Alessandrini, C., Gian-nini, F., Magi, S., Greco, G., Bal-dari, C. T. Cimaz, R. (2010). Colchicine myopathy and neuromy-opathy: two cases with different characteristics. J. Clin. Rheumatol. 16, 229-232.
13. Cervellin, G., Comelli, I., and Lippi, G. (2010). Rhabdomyolysis: histor-ical background, clinical, diagnos-tic and therapeutic features. Clin. Chem. Lab. Med. 48, 749-56.
14. Chawla, J. (2007). "Critical illness polyneuropathy and myopathy," in The Interface of Neurology and Inter- nal Medicine, ed. J. Biller (Philadel-phia, PA: Lippincott Williams & Wilkins), 809-812.
15. Chawla, J., and Gruener, G. (2010). Management of critical illness polyneuropathy and myopathy. Neurol. Clin. 28, 961-977.
16. Chawla, J., Thomas, C., and Fisher, M. (2005). Focal nodular sarcoid myositis: case report and literature review. Case Rep. Clin. Pract. Rev.6, 131-135.
17. Cicala, M. V., and Mantero, F. (2010). Primary aldosteronism: what con-sensus for the diagnosis. Best Pract. Res. Clin. Endocrinol. Metab. 24, 915-921.
18. Crum-Cianflone, N. F. (2008). Bacterial, fungal, parasitic, and viral myositis. Clin. Microbiol. Rev. 21, 473-494.
19. Dabby, R., Sadeh, M., Herman, O., Berger, E., Watemberg, N., Hayek, S., Jossiphov, J., and Nevo, Y. (2006). Asymptomatic or minimally symp-tomatic hyperCKemia: histopatho-logic correlates. Isr. Med. Assoc. J. 8, 110-113.
20. Dalakas, M. C., Rakocevic, G., Shatunov, A., Goldfarb, L., Raju, R., and Sala-jegheh, M. (2007). Inclusion body myositis with human immunode-ficiency virus infection: four cases with clonal expansion of viral-specific T cells. Ann. Neurol. 61, 466-475.
21. de Sanctis, J. T., Cumbo-Nacheli, G., Dobbie, D., and Baumgartner, D. (2008). HIV-associated nemaline rod myopathy: role of intravenous immunoglobulin therapy in two persons with HIV/AIDS. AIDS Read. 18, 90-94.
22. Del Porto, L. A., Liubinas, S. V., and Kaye,A. H. (2011). Treatment of per-sistent and recurrent acromegaly. J. Clin. Neurosci. 18, 181-190.
23. DiMauro, S. (2010). Pathogenesis and treatment of mitochondrial myopathies: recent advances. Acta Myol. 29, 333-338.
24. Distad, B. J., Amato, A. A., and Weiss, M. D. (2011). Inflammatory myopathies. Curr. Treat. Options Neurol. 13, 119-130.
25. Engel, W. K. (1967). Focal myopathic changes produced by electromyo-graphic and hypodermic needles. "Needle myopathy."Arch. Neurol. 16, 509-511.
26. Fernández-Lorente, J., Esteban, A., Salinero, E., Traba, A., Prieto, J., and Palencia, E. (2010). Critical illness myopathy. Neurophysiolog-ical and muscular biopsy assess-ment in 33 patients. Rev. Neurol. 50, 718-726.
27. Filosto, M., Tonin, P., Vattemi, G., Berto-lasi, L., Simonati, A., Rizzuto, N., and Tomelleri, G. (2007). The role of muscle biopsy in investigating isolated muscle pain. Neurology 68, 181-186.
28. Findling, O., Meier, N., Sellner, J., Nedeltchev, K., and Arnold, M. (2008). Clinical reasoning: rhab-domyolysis after combined treat-ment with simvastatin and flucona-zole. Neurology. 71, e34-e37.
29. González-Reimers, E., Durán-Castellón, M. C., López-Lirola, A., Santolaria-Fernández, F., Abreu-González, P., Alvisa-Negrín, J., and Sánchez-Pérez, M. J. (2010). Alcoholic myopathy: vitamin D deficiency is related to muscle fibre atrophy in a murine model. Alcohol Alcohol. 45, 223-230.
30. Gutiérrez-Gutiérrez, G. (2010). Toxic myopathies caused by industrial, animal and vegetal toxins. Rev. Neurol. 51, 360-366.
31. Habib, Z., and Camacho, P. (2010). Primary hyperparathyroidism: an update. Curr. Opin. Endocrinol. Diabetes Obes. 17, 554-560.
32. Heckmann, J. M., Pillay, K., Hearn, A. P., and Kenyon, C. (2010). Polymyosi-tis in African HIV-infected sub-jects. Neuromuscul. Disord. 20, 735-739.
33. Hiromatsu, K., Kobayashi, T., Fujii, N., Itoyama, Y., Goto, I., and Murakami, J. (1994). Hyperna-tremic myopathy. J. Neurol. Sci. 122, 144-147.
34. Horak, H. A., and Pourmand, R. (2000). Endocrine myopathies. Neurol. Clin. 18, 203-213.
35. Jackson, C. E. (2008). A clinical approach to muscle diseases. Semin. Neurol. 28, 228-240.
36. Johnson, E. W., Braddom, R., and Wat-son, R. (1971). Electromyographic abnormalities after intramuscular injections. Arch. Phys. Med. Rehabil. 52, 250-252.
37. Joy, J. L., and Oh, S. J. (1989). Asymptomatic hyper-CK-emia: an electrophysiologic and histopatho-logic study. Muscle Nerve 12, 206-209.
38. Kanda, F., Okuda, S., Matsushita, T., Takatani, K., Kimura, K. I., and Chi-hara, K. (2001). Steroid myopathy: pathogenesis and effects of growth hormone and insulin-like growth factor-I administration. Horm. Res. 56(Suppl. 1), 24-28.
39. Kasaoka, S., Todani, M., Kaneko, T., Kawamura, Y., Oda, Y., Tsuruta, R., and Maekawa, T. (2010). Peak value of blood myoglobin predicts acute renal failure induced by rhabdomy-olysis. J. Crit. Care. 25, 601-604.
40. Kawachi, Y., Koike, Y., Kano, T., Furuta, J., Fujisawa,Y., Nakamura,Y., Ishii, Y., Takahashi, T., and Otsuka, F. (2008). Paraneoplastic dermato-myositis triggered and exacerbated by oral 5-fluorouracil administra-tion. Eur. J. Dermatol. 18, 195-196.
41. Klopstock, T. (2008). Drug-induced myopathies. Curr. Opin. Neurol. 21, 590-595.
42. Kotsaftis, P., Savopoulos, C., Aga-pakis, D., Ntaios, G., Tzioufa, V., Papadopoulos,V.,Fahantidis,E.,and Hatzitolios, A. (2009). Hypokalemia induced myopathy as first mani-festation of primary hyperaldos-teronism - an elderly patient with unilateral adrenal hyperplasia: a case report. Cases J. 2, 6813.
43. Kumar, K., Guirgis, M., Zieroth, S., Lo, E., Menkis, A. H., Arora, R. C., and Freed, D. H. (2011). Influenza myocarditis and myosi-tis: case presentation and review of the literature. Can. J. Cardiol. 27, 514-522.
44. Kuncl, R. W. (2009). Agents and mecha-nisms of toxic myopathy. Curr. Opin. Neurol. 22, 506-515.
45. Kung, A. W. (2007). Neuromuscu-lar complications of thyrotoxicosis. Clin. Endocrinol. (Oxf.) 67, 645-650.
46. Kung, D. H., Hubenthal, E. A., Kwan, J. Y., Shelburne, S. A., Goodman, J. C., and Kass, J. S. (2011). Toxo-plasmosis myelopathy and myopa-thy in an AIDS patient: a case of immune reconstitution inflam-matory syndrome? Neurologist 17, 49-51.
47. Mansourian, A. R. (2010). A review on hyperthyroidism: thyrotoxicosis under surveillance. Pak. J. Biol. Sci. 13, 1066-1076.
48. Marie, I. (2011). Therapy of polymyosi-tis and dermatomyositis. Presse Med. 40(4 Pt 2), e257-e270.
49. Nadaj-Pakleza, A., Kierdaszuk, B., and Kaminska, A. (2010). The role of skeletal muscle biopsy in the diag-nosis of neuromuscular disorders. Neurol. Neurochir. Pol. 44, 481-491.
50. Ning, L., Sippel, R., Schaefer, S., and Chen, H. (2009). What is the clinical significance of an elevated parathy-roid hormone level after curative surgery for primary hyperparathy-roidism? Ann. Surg. 249, 469-472.
51. Nishigori, K., Yamamoto, T., and Yokozeki, H. (2009). Vesiculo-bullous dermatomyositis: report of three cases. Dermatol. Online J. 15, 6.
52. Noordzij, M., Boeschoten, E. W., Bos, W. J., Dekker, F. W., Bossuyt, P. M., Krediet, R. T., Krediet, R. T., Kore-vaar, J. C., and for the NECOSAD Study Group. (2007). Disturbed mineral metabolism is associated with muscle and skin complaints in a prospective cohort of dialysis patients. Nephrol. Dial. Transplant. 22, 2944-2949.
53. Nozaki, K., and Pestronk, A. (2009). High aldolase with normal creatine kinase in serum predicts a myopathy with perimysial pathology. J. Neurol. Neurosurg. Psychiatr. 80, 904-908.
54. O'Connor, G., and McMahon, G. (2008). Complications of heroin abuse. Eur. J. Emerg. Med. 15, 104-106.
55. Pereira, R. M., and Freire de Car-valho, J. (2011). Glucocorticoid-induced myopathy. Joint Bone Spine 78, 41-44.
56. Prabhala, A., Garg, R., and Dandona, P. (2000). Severe myopathy associated with vitamin D deficiency in west-ern NewYork. Arch. Intern. Med. 160, 1199-1203.
57. Radcliffe, K. A., and Campbell, W. W. (2008). Statin myopathy. Curr. Neurol. Neurosci. Rep. 8, 66-72.
58. Ramchandren, S., and Dalmau, J. (2005). Metastases to the peripheral nervous system. J. Neurooncol. 75, 101-110.
59. Rothschild, B. (2010). Acrylamine-induced autoimmune phenomena. Clin. Rheumatol. 29, 999-1005.
60. Schwager, S., Hochuli, M., and Jung, H. H. (2010). Muscle weakness: dif-ferential diagnosis and assessment. Praxis (Bern 1994). 99, 1121-1129; quiz 1129-1130.
61. Scruggs, E. R., and Dirks Naylor, A. J. (2008). Mechanisms of zidovudine-induced mitochondrial toxicity and myopathy. Pharmacology 82, 83-88.
62. Selcen, D. (2011). Myofibrillar myopathies. Neuromuscul. Disord. 21, 161-171.
63. Silver, R. M., Sutherland, S. E., Car-reira, P., and Heyes, M. P. (1992). Alterations in tryptophan metabo-lism in the toxic oil syndrome and in the eosinophilia-myalgia syndrome. J. Rheumatol. 19, 69-73.
64. Srinivasan, J., and Amato, A. A. (2003). Myopathies. Phys. Med. Rehabil. Clin. N. Am. 14, 403-434.
65. Streichenberger, N., Meyronet, D., Fiere, V., Pellissier, J. F., and Petiot, P. (2004). Focal myositis associated with S-1 radiculopathy: report of two cases. Muscle Nerve 29, 443-446.
66. Syriou, V., Kolitsa, A., Pantazi, L., and Pikazis, D. (2005). Hypoparathy-roidism in a patient presenting with severe myopathy and skin rash. Case report and review of the literature. Hormones (Athens) 4, 161-164.
67. Tien-Auh Chan, A., Kirton, C., Estanis-lao, L., and Simpson, D. M. (2007). Myopathy in HIV infection. Handb. Clin. Neurol. 85, 139-145.
68. Tsuda, E., Imai, T., Matsumura, A., Hisahara, S., Nonaka, M., Shiraishi, H., Motomura, M., and Shimohama, S. (2008). Thyrotoxic myopathy mimicking myasthenic syndrome associated with thymic hyperplasia. Intern. Med. 47, 445-457.
69. Turker, H., Bayrak, O., Gungor, L., Yil-maz, A., Terzi, M., Turker, C. M., Onar, M. K., and Kahraman, H. (2008). Hypothyroid myopathy with manifestations of Hoffman's syn-drome and myasthenia gravis. Thyroid 18, 259-262.
70. Volpi, L., Ricci, G., Orsucci, D., Alessi, R., Bertolucci, F., Piazza, S., Simoncini, C., Mancuso, M., and Siciliano, G. (2011). Meta-bolic myopathies: functional eval-uation by different exercise testing approaches. Musculoskelet. Surg. 95, 59-67.
71. Weis, J., and Nolte, K. (2009). Inflam-matory and other myopathies and skeletal muscle vasculitis: the role of muscle and nerve biopsy. Z. Rheumatol. 68, 459-464.
72. Yildirim Donmez, F., and Feldman, F. (2008). Muscle compromise in diabetes. Acta Radiol. 49, 673-679.